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Abstract: Strongyle infection was detected in 68% of 320 horses from 9 farms in western Turkey. Egg counts per gram of faeces
(EPG) were more than 950 in half of the animals. The persistent efficacy of 3 different anthelmintics to suppress cyathostome EPG
was compared on a horse farm. One group of horses was treated with moxidectin on day 0, and the 2 other groups received pyrantel
embonate or ivermectin on days 0 and 70. Pyrantel embonate reduced the EPG by >90% for 2 weeks; thereafter egg counts steadily
increased. Ivermectin reduced the EPG by >98% for up to 6 weeks. In contrast, one treatment with moxidectin resulted in a
persistent efficacy of >98% for at least 16 weeks.
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Türkiye Atlar›nda Strongylidae Enfeksiyonlar›n›n Yay›l›fl› ve Pyrantel Embonate, ‹vermectin ve
Moxidectinin Etki Süreleri
Özet: Türkiye’nin bat›s›nda yer alan dokuz at çiftli¤indeki 320 at›n % 68’inde Strongylidae enfeksiyonu saptanm›flt›r. Atlar›n
yar›s›nda, gram d›flk›daki yumurta say›s›n›n (EPG) 950’den yüksek oldu¤u belirlenmifltir. Çiftliklerden birinde üç farkl› antelmenti¤in
Cyathostominae EPG’lerine etki süreleri karfl›laflt›r›lm›flt›r. Bir grup at 0. gün moxidectin ile, di¤er iki grupta bulunan atlar ise 0. ve
70. günlerde pyrantel embonate ve ivermectin ile tedavi edilmifllerdir. Pyrantel embonate 2 hafta boyunca EPG de¤erini >% 90
oran›nda azaltm›fl, yumurta say›lar› daha sonra artmaya bafllam›flt›r. ‹vermectin ise EPG miktar›n› 6 hafta süresince >% 98 oran›nda
azaltm›flt›r. Buna karfl›l›k moxidectin ile yap›lan tek tedavinin etki süresi en az 16 hafta boyunca >% 98 olmufltur.
Anahtar Sözcükler: Strongylidae, at, ivermectin, moxidectin, pyrantel embonate

Introduction
One of the important parasitic diseases of horses is
strongylosis, caused by strongyle nematodes. Overall, the
prevalence of strongyles is generally high worldwide (13). The prevention of strongylosis relies mainly on
suppressive anthelmintic treatments during the grazing
season. There have been numerous comparisons of the
suppression of faecal egg output with different
anthelmintics like pyrantel, ivermectin and moxidectin (48).
In Turkey 271,000 horses are kept according to the
official veterinary census (9), and it is estimated that
approximately 11,000 of them are thoroughbreds for

horse races. In recent years several investigations have
been performed to elucidate the gastrointestinal parasite
fauna of equines in Turkey; however, these studies mainly
focused on draught and breeding horses, donkeys or
mules in rural regions (10-12). Knowledge on the
parasitological situation in Turkish stud farms is rather
scanty (13). In spite of missing information on both
epidemiological principles as well as on the different
potencies of available drugs, and just because of this lack
of knowledge current helminth control practices rely on
irregular, often wrongly dated and unnecessary use of
anthelmintics on many of these farms. This also implies
an increasing risk for the development of anthelmintic
resistance in equine nematode populations.

* e-mail: vcirak@uludag.edu.tr

175

The Prevalence of Strongyle Infections and Persistent Efficacy of Pyrantel Embonate, Ivermectin and Moxidectin in Turkish Horses

Therefore, the aims of the present investigation were
first to determine the current prevalence of strongyle
infections in horses from large farms in western Turkey
and second to evaluate the persistent efficacy of 3
anthelmintic drugs, i.e. pyrantel embonate, ivermectin
and moxidectin, under local conditions.
Materials and Methods
Cross-sectional survey
The survey was performed on 320 horses, most of
them thoroughbreds, from 8 stud farms and 1 military
property in western Turkey. Parasite control of the farms
was mainly based on irregular applications of anthelmintic
drugs like ivermectin, doramectin, benzimidazoles,
tetramisole or levamisole, and the reported deworming
frequency varied between 2 and 6 per horse and year.
Horses under investigation were 10 months to 18 years
of age, of different sex and had not been anthelmintically
treated during the previous 3 to 5 months according to
the information given by the farm managers. Faecal
samples were collected during summer months and
examined for strongyle egg counts using a modified
McMaster technique with a sensitivity of 50 eggs per
gram of faeces (EPG) (14). Pooled faecal samples were
cultured for larval differentiation, and where possible
100 third-stage larvae were identified (15).
Additionally, faecal samples were collected from the
same horses and examined as described on 2 occasions 2
to 5 days (n = 134 animals) or 2 weeks apart (n = 59
animals) to assess the repeatability of egg counts. The
correlation between the duplicate EPG was evaluated
using Spearman´s rank correlation coefficient (rs) with a
statistical software package (16).
Persistence efficacy trial
The trial was carried out on a state Arabian
Thoroughbred farm in the south Marmara region,
Turkey. On this farm ivermectin and thiabendazole had
been irregularly used in previous years. A total of 48
female horses, naturally infected with strongyles, were
selected for the trial. The animals were 10 months to 2
years of age and had not been treated with anthelmintics
in the previous 4 months. All animals grazed together on
permanent horse pasture throughout the year. Horses
were ranked on the basis of pre-treatment faecal egg
counts and randomly allocated to 4 groups of 12 animals
each. On day 0, 3 groups of horses were treated with
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pyrantel embonate (Bivantel® 40% paste, Boehringer
Ingelheim, Germany; group P), ivermectin (Eqvalan®
1.87% paste, Merial or Eraquell® 1.87% paste, Virbac,
Germany; group I) or moxidectin (Equest® 1.89% gel,
Fort Dodge, Germany; group M) at the recommended
dose rates of 19 mg/kg body weight (BW), 0.2 mg/kg
BW and 0.4 mg/kg BW, respectively. Animals in group C
remained untreated as controls; they were discarded
from the trial after week 10. Group P and I horses were
re-treated 10 weeks after the first treatment. BWs were
estimated by means of a heart girth tape to calculate the
appropriate dose for each horse. All treatments were
given orally by one of the authors. Horses were observed
for approximately 5 min after treatment to verify dose
retention. No adverse reactions were recorded. Individual
faecal samples were examined for strongyle egg counts
and group faecal cultures were performed before
treatments and then at 2-week intervals until trial week
16, when most of the young mares were sold.
Additionally, 6 and 4 horses of groups P and M,
respectively, were available for faecal examinations on
week 25. Arithmetic mean EPG was calculated for each
group on each sampling date. The percentage of faecal
egg count reduction (FECR) in treated groups was
calculated according to the formula
FECR (%) = ((mean EPGDay 0 – mean EPGDay 0+Y) /
mean EPGDay 0) x 100,
With ‘Day 0+Y’ meaning the respective sampling date
post-treatment. Data were analysed for statistical
significance (P < 0.01) by the Mann-Whitney U test (7).

Results
Prevalence of strongyle infections
Patent strongyle infections were detected in 219
(68.4%) of 320 horses examined once 3 to 5 months
after the last anthelmintic treatment (Figure 1). Half of
the animals shed more than 950 EPG (median), and a
maximum egg shedding as high as 14,300 EPG was
found in 1 horse. All 9 farms harboured egg-positive
horses. The within-farm prevalence and mean withinfarm EPG ranged from 43% to 100% and from 185 to
2358, respectively (Table 1). Larvae of small strongyles
(cyathostomes) were isolated from faecal cultures almost
exclusively; Strongylus spp., Triodontophorus spp.,
Poteriostomum spp. and Strongyloides westeri larvae
occurred in a few cases.
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Figure 1. Frequency distribution of strongyle EPG in 320 horses of different age and sex from 9
farms in western Turkey (last anthelmintic treatments 3-5 months prior to
examination).

Table 1. Within-farm prevalence of strongyle infections and mean
within-farm EPG in 9 horse farms in western Turkey (last
anthelmintic treatments 3-5 months prior to examination).
Farm

Within-farm
prevalence (%)

Mean within-farm
EPG

A

100

1946 (± 1142)A

B

57

489 (± 767)

C

43

403 (± 1010)

D

79

661 (± 634)

E

45

185 (± 426)

F

58

817 (± 1226)

G

67

2358 (± 4040)

H

69

1881 (± 2192)

I

58

238 (± 292)

and after treatments only cyathostome larvae were found
in faecal cultures. The egg output of untreated control
animals varied slightly during the trial. Pyrantel embonate
significantly suppressed the EPG by 90% to 95% 2
weeks after first and second treatment. However, mean
egg counts steadily increased and from 8 weeks posttreatment had nearly reached the level on day 0.
Ivermectin significantly reduced the EPG by >98% for up
to 6 weeks; from 8 weeks post-treatment mean egg
counts exceeded 200 EPG. In contrast, strongyle egg
output was negative or very low on all sampling dates
after moxidectin treatment, resulting in a significantly
persistent efficacy of >98% for at least 16 weeks. In
addition, 4 horses of group M available in week 25 still
showed low egg counts.

A

Standard deviation in parentheses.

Discussion
Duplicate EPG were strongly correlated with each
other if the sampling interval was 2 to 5 days. However,
the correlation between 2 egg counts taken 2 weeks
apart was low and not significant (Figure 2).
Persistence of faecal egg count suppression
Table 2 and Figure 3 show the course of mean egg
counts and the percentage of efficacy throughout the trial
period, respectively. All horses shed high levels of
strongyle eggs at the start of the trial, indicating a
considerable infection risk on this farm. In all cases before

The results of the present survey clearly demonstrate
that strongyle infections are highly prevalent in stud
farms in western Turkey. This is in line with previous
reports from both Turkey (10-13) and other countries
(2,3), which indicate prevalence rates varying between
62.7% and 100%. High mean EPG levels were observed
in several premises; however, generally most animals
passed low egg counts and high counts concerned only a
few animals on a farm (Table 1; Figure 1). The skewed
frequency distribution of EPG in horses exactly
corresponds with the well-known fact that both worm
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Figure 2. Correlation of 2 consecutive strongyle EPG of the same horses for 2 sampling intervals
(2 to 5 days; 2 weeks).

Table 2:. Arithmetic mean strongyle EPG and numbers of positive animals in groups of young horses untreated (C) or treated with moxidectin (M),
ivermectin (I) and pyrantel embonate (P). Groups grazed together on permanent pasture.
Mean EPG (number of positive horses) in week
Group

No. of
horses

0A

2

4

6

8

10B

12

14

16

25C

C

12

1721
(12)

1500
(12)

2417
(12)

1254
(12)

2238
(12)

2804
(12)

nc

nc

nc

nc

P

12

2105
(12)

105
(10)

336
(8)

341
(12)

1650
(12)

1568
(12)

155
(9)

68
(7)

259
(10)

3300

I

12

1521
(12)

4
(1)

15
(1)

17
(1)

221
(9)

696
(9)

0
(0)

0
(0)

0
(0)

nc

M

12

2283
(12)

0
(0)

0
(0)

0
(0)

0
(0)

0
(0)

4
(1)

0
(0)

27
(2)

25

A

First treatment of groups P, I and M.
Second treatment of groups P and I; discarding group C from the trial.
C
Calculated for 6 and 4 horses of groups P and M, respectively; other horses had been sold.
nc = not calculated.
B
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Figure 3. Time course of mean faecal egg count reduction (FECR) percentage in
groups of young horses treated orally with moxidectin, ivermectin and
pyrantel embonate. Groups grazed together on permanent pasture.

burdens and EPG are overdispersed, e.g., in ruminants
(17). The question of overdispersion is relevant to the
identification and possible selection of animals for genetic
resistance to nematodes. Faecal egg counts were shown to
be an appropriately phenotypic criterion to identify in sheep
those animals that are genetically superior in terms of
resistance to trichostrongyle infection (18). The usefulness
of a method to assess the parasite resistance of a host in
breeding studies depends, in part, on its repeatability. The
repeatability of a parameter such as EPG is the correlation
between repeated measurements on the same animal, and
repeatability analysis is a simple way to determine whether
quantitative genetic analysis will be profitable. Similar to
previous observations on trichostrongyle egg shedding in
sheep (19) the repeatability of EPG in horses was high
when samples were collected at short intervals of 2 to 5
days but fell to an insignificant level when the interval was
longer (Figure 2). Therefore, it may be of interest to
elucidate in future the question of whether differences in
susceptibility to nematodes also exist in equines and in this
case faecal egg counts are useful tools to look for ‘strongyle
resistant’ horses.

In the second part of our investigation the 3
anthelmintic drugs (paste formulations for use in equines)
resulted in a high reduction in patent strongyle infections.
However, strong differences were observed in their
persistence to suppress the egg output for a period of
time. Four to six weeks after administration of pyrantel
embonate, which is effective against adult strongyles only
(20), the egg counts were increasing again. These results
correspond with previous reports (4,6,21). Ivermectin
reduced the EPG by >98% for up to 6 weeks, and 8
weeks post-treatment increasing egg counts were seen in
our trial. This confirms data from others (4,6,8); in some
studies ivermectin covered a period of even 10 to 12
weeks (5,7,22). Moxidectin resulted in a >98%
suppression of strongyle egg counts for at least 16
weeks. This relatively new anthelmintic was first
evaluated in horses in Turkey as an off-label used
injectable formulation and the efficacy was 100% at a
dose rate of 0.3 mg/kg BW (23). It suppressed the
strongyle egg output by 99% for 8 weeks (7), >90% for
12 weeks (6,8,24) and 95% for 25 weeks (25).
179
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In agreement with many previous studies our data
clearly demonstrate that pyrantel embonate, ivermectin
and moxidectin differ in their persistent effect. The
different potency of these (and other) drugs is of practical
importance: anthelmintic control programmes in stud
farms should be based on the so-called ‘egg reappearance
period’ (ERP) of the respective compound. The ERP is
that period after anthelmintic treatment in which mean
egg counts do not exceed a specific level of, e.g., 200
EPG. An exceeding of this level indicates the necessity for
re-treatment.
In conclusion, considering the high prevalence rates of
strongyle infections in Turkish stud farms, anthelmintics

with longer persistent efficacy should be used to minimise
the risk of reinfections due to strongyles.

Acknowledgements
We are grateful to Mr. Yıldırım and Mr. Durmaz for
their kind cooperation as well as to the farm managers of
the horse premises and especially the General Directorate
of Agricultural Farms (T‹GEM) for their permission to
perform the efficacy trial on the farm. The authors also
acknowledge the donations of anthelmintic drugs for this
trial from Boehringer Ingelheim Germany, Fort Dodge
Germany and Virbac Germany.

References
1.

Lyons, E.T., Tolliver, S.C., Drudge, J.H.: Historical perspective of
cyathostomes: prevalence, treatment and control programs. Vet.
Parasitol., 1999; 85: 97-112.

11.

Arslan, M.Ö., Umur, fi.: Kars yöresinde at ve efleklerde bulunan
helmint ve Eimeria (Protozoon) türleri. T. Parazitol. Derg. 1998;
22: 180-184.

2.

Osterman Lind, E., Hoglund, J., Ljungstrom, B.L., Nilsson, O.,
Uggla, A.: A field survey on the distribution of strongyle infections
of horses in Sweden and factors affecting faecal egg counts.
Equine Vet. J., 1999; 31: 68-72.

12.

Gül, A., De¤er, S., Ayaz, E.: Türkiye’nin farklı illerinde dıflkı
muayenesine göre tektırnaklılarda bulunan helmint türleri ve
yayılıflı. Turk. J. Vet. Anim. Sci., 2003; 27: 195-199.

13.

3.

Rehbein, S., Visser, M., Winter, R.: Examination of faecal samples
of horses from Germany and Austria. Pferdeheilkunde., 2002;
18: 439.

Öge, H.: Dıflkı bakılarına göre atlarda helmint enfeksiyonlarının
genel durumu. PhD Dissertation. Ankara University, Ankara,
Turkey. 1991

14.

4.

Parry, J.M., Fisher, M.A., Grimshaw, W.T., Jacobs, D.E.:
Anthelmintic dosing intervals for horses: comparison of three
chemical groups. Vet. Rec., 1993; 133: 346-347.

Bauer, C.: Praktikum der Veterinärmedizinischen Parasitologie.
Ferbersche Universitätsbuchhandlung, Giessen. 1990; 58-60.

15.

MAFF: Manual of Veterinary Parasitological Laboratory
Techniques. Reference Book 418. 3rd ed., Ministry of
Agriculture, Fisheries and Food, HMSO, London. 1986.

16.

Ackermann, H.: BiAS für Windows. Version 7.06. Epsilon,
Darmstadt. 2002.

17.

Stear, M.J., Bairden, K., Duncan, J.L., Gettingby, G., McKellar,
Q.A., Murray, M., Wallace, D.S.: The distribution of faecal
nematode egg counts in Scottish Blackface lambs following
natural, predominantly Ostertagia circumcincta infection.
Parasitology., 1995; 110: 573-581.

18.

Bisset, S.A., Morris, C.A., McEwan, J.C., Vlassoff, A.: Breeding
sheep in New Zealand that are less reliant on anthelmintics to
maintain health and productivity. New Zeal. Vet. J., 2001; 49:
236-246.

19.

Stear, M.J., Bishop, S.C., Duncan, J.L., McKellar, Q.A., Murray,
M.: The repeatability of faecal egg counts, peripheral eosinophil
counts, and plasma pepsinogen concentrations during deliberate
infections with Ostertagia circumcincta. Int. J. Parasitol., 1995;
25: 375-380.

20.

Lyons, E.T., Drudge, J.H., Tolliver, S.C.: Critical tests of three
salts of pyrantel against internal parasites of the horse. Am. J.
Vet. Res., 1974; 35: 1515-1522.

5.

Jacobs, D.E., Hutchinson, M.J., Parker, L., Gibbons, L.M.: Equine
cyathostome infection: suppression of faecal egg output with
moxidectin. Vet. Rec., 1995; 137: 545.

6.

Taylor, S.M., Kenny, J.: Comparison of moxidectin with
ivermectin and pyrantel embonate for reduction of faecal egg
counts in horses. Vet. Rec., 1995; 137: 516-518.

7.

Demeulenaere, D., Vercruysse, J., Dorny, P., Claerebout, E.:
Comparative studies of ivermectin and moxidectin in the control
of naturally acquired cyathostome infections in horses. Vet. Rec.,
1997; 141: 383-386.

8.

Rolfe, P.F., Dawson, K.L., Holm-Martin, M.: Efficacy of
moxidectin and other anthelmintics against small strongyles in
horses. Aust. Vet. J., 1998; 76: 332-334.

9.

Republic of Turkey, Prime Ministry State Institute of Statistics:
Number
of
livestock
by
kind.
SIS
2000
(http://www.die.gov.tr/IstTablolar/13ta177t.xls).

10.

Demir, S., Tınar, R., Aydın, L., Çırak, V.Y., Ergül, R.: Bursa yöresi
tektırnaklılarında dıflkı muayenesi ile saptanan helmint türleri ve
yayılıflı. T. Parazitol. Derg., 1995; 19: 124-131.

180

V. Y. ÇIRAK, E. GÜLE⁄EN, C. BAUER

21.

Boersema, J.H., Borgsteede, F.H., Eysker, M., Saedt, I.: The
reappearance of strongyle eggs in faeces of horses treated with
pyrantel embonate. Vet. Quart., 1995; 17: 18-20.

24.

Reinemeyer, C.R., Clymer, B.C.: Comparative efficiency of
moxidectin gel or ivermectin paste for cyathostome control in
young horses. J. Equine Vet. Sci., 2002; 22: 33-36.

22.

Alzieu, J.P., Bourdenx, L., Alzieu, C., Flochlay, A., Blond-Riou, F.,
Dorchies, P.: Persistance de l’activité d’un gel oral à 2% de
moxidectine sur les strongles gastro-intestinaux de chevaux
infestés naturellement. Résultats d’un essai dans Sud-Quest
francais. Bull. des G.T.V., 1997; 5: 79-83.

25.

Boersema, J.H., Eysker, M., Van der Aar, W.M.: The
reappearance of strongyle eggs in the faeces of horses after
treatment with moxidectin. Vet. Quart., 1998; 20: 15-17.

23.

Gülanber, A., Tüzer, E., Gargılı, A., Toparlak, M., Efil, I., Kelefl,
V., Ulutafl, M.: Efficacy of moxidectin against strongylin
nematodes in naturally infected horses. Tr. J. of Vet. Anim. Sci.,
1998; 22: 465-466.

181

